Similarly, the apoptosis gene marker BAX exhibited a significant upregulation in experimental subgroup 2 compared to both the control and the ischemia group, while the anti-apoptotic BCL2 gene expression remained unchanged. The gene discussed is BAX; the disease is ischemia.